STUDY OF DRUG COMPLIANCE AMONG DIABETIC PATIENTS
Diabetes is one of the most common ailments that the general population suffer in todayâ€™s world. Some are aware about their disturbing blood sugar levels and even understand the importance of appropriate control of the levels with the right medications. Some are aware and yet ignorant due to various causes. This study is aimed at evaluating the drug compliance among type 2 diabetes patients attending the review op of the department of Diabetology, KMCH. A study group of 100 patients attending the review OP were enrolled in the study. The compliance was assessed with the help of their diabetic OP records and a pretested questionnaire was used to further dig into the possible causes for non compliance. The study is broadly based on two main factors leading to non-compliance-causes for patients not getting medicines regularly and causes for patients not taking medicines regularly. These two factors were analyzed based on gender, age, duration of diabetes, co morbid illness, distance etc. The results have shown that 39% of the patients were not getting the medications regularly, out of which 33.3% did not get it due to sheer laziness,38.5% were forgetful and other serious illness hindered 28.2% of the patients from getting their medications. It was found that 55% of the patients took their medications regularly. Among those who took medications regularly,80.3% were regular and 15.4% were not regular in getting medications. AmongÂ those who did not take medications regularly,66.7% claimed to be forgetful and 46.7% were non complaint as they did not have adequate knowledge about their medications.33.3% of the patients did not take it regularly as it gave them a feeling of wellbeing which tempted them to skip doses. Based on these significant data, we will be able to suggest ways and measures to improve the compliance on the treatment aspect. This would increase the desired therapeutic outcome and ultimately, on a broad aspect, it will reduce national health costs.Key words: drug compliance, therapeutic outcome
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).